earth.com
Crohn's patients changed to this diet, and most noticed significant improvement - Earth.com
Many people with Crohn’s ask whether specific diets can reduce inflammation rather than only avoiding triggers. This randomized trial reports symptom and stool-marker improvements with a brief, repeated plant-based meal-kit plan, suggesting diet may help as an adjunct for some patients.
Adults with Crohn’s disease (especially colonic or ileocolonic disease), clinicians who manage IBD, dietitians, and researchers studying diet, biomarkers, or immune pathways in IBD.
What To Know
A short monthly, five-day plant-based meal-kit diet was tested in a randomized trial of adults with mild-to-moderate Crohn’s disease and reported symptom improvement and lower stool inflammation (fecal marker) over three months.
The trial was open-label, benefits appeared stronger for colonic or ileocolonic disease, effects waned when participants stopped the monthly cycles, and the study authors reported a commercial tie to the meal-kit maker. Camera (endoscopic) confirmation was rare in follow-up.
This study suggests a brief, repeatable plant-based “reset” eaten five days each month was associated with symptom relief and reductions in a stool inflammation marker for many participants, without requiring permanent diet changes.
The trial included blood and stool biomarker measurements and some immune-pathway signals that moved toward less inflammation, but blood inflammation did not meet statistical significance. Side effects during the five-day periods (tiredness, headaches) were generally mild, and most participants adhered to the program.
Practical takeaways: The diet was studied as an add-on, not a replacement for medical care. Results are promising but preliminary: longer studies, independent replication, more endoscopic data, and trials in broader patient groups are needed before this becomes a recommended treatment. Discuss any major diet changes with your care team.
The trial was open-label and used commercial meal kits from a company linked to a coauthor, so independent replication and more endoscopic confirmation are needed. Benefits lessened after stopping the monthly cycles, so long-term effects and feasibility remain unclear.
